Pancreatic Cancer Research

ResearcherCharles UniversityActive in the last 2 years

Árpád Szabó

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-1504-2049; OpenAlex author ID A5030234822. Sources: OpenAlex.

Their work

Papers
10 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
17
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: 1 paper · 2021: 2 papers · 2022: 1 paper · 2023: 1 paper · 2024: 2 papers · 2025: 1 paper

Papers 10

  1. Determinants of Implantation Success in Pancreatic Cancer Patient-Derived Xenografts: Role of Matrigel Application, Histological Subtype, and Time Management. Co-author DOI 10.14712/fb2025.0006↗
  2. Third-generation taxanes SB-T-121605 and SB-T-121606 are effective in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.isci.2024.109044↗
  3. Expression of Selected miRNAs in Undifferentiated Carcinoma with Osteoclast-like Giant Cells (UCOGC) of the Pancreas: Comparison with Poorly Differentiated Pan… Co-author DOI 10.3390/biomedicines12050962↗
  4. Favorable prognostic significance of membranous β-catenin expression and negative prognostic significance of cytoplasmic β-catenin expression in pancreatic can… Co-author DOI 10.4149/neo_2023_230721n380↗
  5. Introducing in vivo pancreatic cancer models for the study of new therapeutic regimens Co-author DOI 10.33699/pis.2022.101.12.584-592↗
  6. Desmoplastic Crosstalk in Pancreatic Ductal Adenocarcinoma Is Reflected by Different Responses of Panc-1, MIAPaCa-2, PaTu-8902, and CAPAN-2 Cell Lines to Cance… Co-author DOI 10.21873/cgp.20254↗
  7. Circulating Tumor Cells, Circulating Tumor DNA and Other Blood-based Prognostic Scores in Pancreatic Ductal Adenocarcinoma - Mini-Review. Co-author DOI 10.21873/invivo.12229↗
  8. Expression of selected microRNAs in pancreatic ductal adenocarcinoma: is there a relation to tumor morphology, progression and patient's outcome? Co-author DOI 10.4149/neo_2020_200123n87↗
  9. Expression of selected MicroRNAs in pancreatic ductal adenocarcinoma in relation to tumor progression and patient’s outcome. First author DOI 10.21203/rs.2.18344/v1↗
  10. Small nucleolar RNA U91 is a new internal control for accurate microRNAs quantification in pancreatic cancer. First author DOI 10.1186/s12885-015-1785-9↗

Closest collaborators

The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Martin Oliverius · 5 shared papers, 2021–2025 · strength 0.93
  2. R Gürlich · 5 shared papers, 2019–2022 · strength 0.64
  3. Tomas Sychra · 3 shared papers, 2022–2025 · strength 0.55
  4. Pavel Souček · 3 shared papers, 2022–2025 · strength 0.55
  5. Václav Mandys · 4 shared papers, 2015–2024 · strength 0.53
  6. Alexey Popov · 4 shared papers, 2015–2024 · strength 0.53
  7. Renata Soumarová · 3 shared papers, 2019–2021 · strength 0.39
  8. Marián Liberko · 3 shared papers, 2019–2021 · strength 0.39
  9. Josef Dvořák · 2 shared papers, 2021–2023 · strength 0.27
  10. Emin Gayibov · 1 shared paper, 2025 · strength 0.22
  11. Jan Hrudka · 1 shared paper, 2024 · strength 0.22
  12. Blanka Rosová · 1 shared paper, 2023 · strength 0.17
  13. Bohuslav Melichar · 1 shared paper, 2023 · strength 0.17
  14. Radoslav Matěj · 1 shared paper, 2023 · strength 0.17
  15. Stepan Novak · 1 shared paper, 2021 · strength 0.10
  16. Pavol Szabó · 1 shared paper, 2021 · strength 0.10
  17. Matúš Čoma · 1 shared paper, 2021 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.